Impact of COVID-19 Pandemic on Human Papillomavirus Vaccine Uptake in Israel

1Gynecologic Oncology Department, Lis Maternity Hospital, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel

2Faculty of Medicine, Tel Aviv University, Ramat Aviv, Tel-Aviv, Israel

3Pediatric Infectious Disease Unit, Dana-Dwek Children's Hospital, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel

Reprint requests to: Michael Lavie, MD, Obstetrics & Gynecology Department, Lis Maternity Hospital, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel. E-mail: [email protected]

IRB Approval – Due to the demographic nature of this study, our institutional review board exempted this study from the need for Helsinki (approval letter April 24, 2022).

The authors have declared they have no conflicts of interest.

All authors fulfilled the conditions required for authorship.

This article has not been published and will not be submitted for publication elsewhere during the period of review.

留言 (0)

沒有登入
gif